Abstract:Background Multiple endocrine neoplasia (MEN) is relatively rare. But more patients could be found by detailed examination. We discuss the diagnosis and surgical treatment of MEN.Methods The clinical data of 95 MEN cases were retrospectively analyzed. There were 30 cases of MEN1 including 19 cases from 6 families. The MEN1 gene mutation was detected in 81.48% of cases admitted after 1997. There were 22 cases of primary hyperparathyroidism (PHPT), 10 cases of enteropanceatic tumor including 9 cases of insulinoma, 15 cases of pituitary adenoma, 9 cases of adrenal adenoma, 2 cases of thymic carcinoid. Two patients had 4 glands involved, 3 patients had 3 glands involved, 16 patients had 2 glands involved, and 6 patients had only one gland involved. Three patients had neither clinical symptoms nor biochemical changes, and was diagnosed by MEN1 gene mutation. Six patients presented with nephrolithasis and 6 patients had impaired pancreatic endocrine function. There were 60 cases of MEN2a and 5 cases of MEN2b. 58 cases of MEN2a belongs to 19 kindreds. All MEN2a patients but one presented RET gene mutation in codon 634, and all MEN2b cases had mutation in codon 918. 48 cases of MEN2a had thyroid masses with elevated calcitonin levels. 27 patients had pheochromocytoma including 12 cases of multiple foci and 5 malignancy. 13 patients presented with hyperparathyroidism. 5 MEN2b patients had medullary thyroid carcinoma and mucosal ganglioneuromatosis with Marfanoid. Among them, 3 patients had bilateral pheochromocytoma.Results In MEN1, subtotal parathyroidectomy was performed in 12 patients with PHPT and one patient received parathyroid adenoma enucleation. Insulinomas were enucleated in 4 patients. Two patients underwent thymus tumor extirpation. Total thyroidectomy with bilateral dissection of regional lymph nodes was performed in 16 patients with MEN2a and nodule enucleation was performed in 9 patients. Twenty two MEN2a patients underwent pheochromocytoma enucleation including bilateral adrenal resection in 10 cases. 5 MEN2b patients underwent total thyroidectomy with bilateral lymph node dissection. Among them, 3 cases underwent bilateral adrenal operations.Conclusions MEN varies in symptoms. Germline mutation test is helpful in establishing a diagnosis. Surgical management should be aimed at the improvement of life quality in MEN1 and prevention of the fetal tumors in MEN2. Chin Med J 2009; 122(13):1495-1500

Advances of the Research on Multiple Endocrine Neoplasia

The Trends in Early Precision Diagnosis and Treatment Strategies of Multiple Endocrine Neoplasia Type 2

5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine

Updates on the genetics of multiple endocrine neoplasia

A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis

Diagnosis and Surgical Treatment of Multiple Endocrine Neoplasia.

Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma

Evaluation and Surgical Management of Multiple Endocrine Neoplasias

Clinical Characteristics of Multiple Endocrine Neoplasia : an Analysis of 6 Cases

p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report

MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1.

Genetics, Clinical Heterogeneity and Modifying Genes

Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results

The clinical features of multiple endocrine neoplasia type 2A (MEN2A)and ret proto-oncogene mutation study

Role of Nutrition in the Management of Patients with Multiple Endocrine Neoplasia Type 1

[Genotype-phenotype correlations in multiple endocrine neoplasia type 2]

MEN2-related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives

Multiple Endocrine Neoplasia Type 1 Simultaneous with Various Types of Enteropancreatic Endocrine Tumors One Case Report: Lessons Learned

Multiple Endocrine Neoplasia Type 1 (MEN I, Wermer Syndrome)

Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?

Cellular Mechanisms of RET Receptor Dysfunction in Multiple Endocrine Neoplasia 2